Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction

Area of Science:

• Biomarker discovery
• Cardiovascular research
• Molecular biology

Background:

• Left ventricular (LV) dysfunction and heart failure (HF) are common after myocardial infarction (MI).
• Current HF biomarkers offer limited prognostic information post-MI.
• Novel biomarkers are needed to predict cardiac dysfunction after MI.

Purpose of the Study:

• To identify novel prognostic biomarkers for LV dysfunction following acute MI.
• To combine protein interaction network analysis with gene expression profiling.
• To discover biomarkers with superior predictive value compared to established markers.

Main Methods:

• Constructed and analyzed an angiogenesis-related protein-protein interaction network.
• Performed microarray analysis on blood cells from 127 acute MI patients.
• Utilized prediction analysis to identify a gene set for predicting LV dysfunction (EF < or = 40%).

Main Results:

• Identified a 53-protein cluster involved in cell growth regulation within the angiogenesis network.
• Found 38 differentially expressed genes between low and high LV ejection fraction (EF) groups.
• A set of three genes (VEGFB, TSP1, PGF) predicted LV dysfunction with an AUC of 0.82, outperforming BNP and troponin T (AUC 0.63).

Conclusions:

• A novel strategy combining network analysis and gene expression successfully identified potential prognostic biomarkers for post-MI LV dysfunction.
• Vascular Endothelial Growth Factor B (VEGFB), Thrombospondin-1 (TSP1), and Placental Growth Factor (PGF) show promise as superior biomarkers.
• Further validation in larger patient cohorts is required to confirm the clinical utility of these novel biomarkers.